Avaliação da perda da visão

Rossi T, Boccassini B, Iossa M, et al. Triaging and coding ophthalmic emergency: the Rome Eye Scoring System for Urgency and Emergency (RESCUE): a pilot study of 1,000 eye-dedicated emergency room patients. Eur J Ophthalmol. 2007 May-Jun;17(3):413-7. Resumo

National Institute for Health and Care Excellence. Glaucoma: diagnosis and management. Jan 2022 [internet publication].Texto completo

Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74. Resumo

Donahue SP, Baker CN; American Academy of Pediatrics; American Association of Certified Orthoptists; American Association for Pediatric Ophthalmology and Strabismus; American Academy of Ophthalmology. Procedures for the evaluation of the visual system by pediatricians. Pediatrics. 2016 Jan;137(1). (Reaffirmed Feb 2022).Texto completo  Resumo

1. World Health Organization. Blindness and vision impairment. Oct 2022 [internet publication].Texto completo

2. GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021 Feb;9(2):e144-60Texto completo  Resumo

3. Rossi T, Boccassini B, Iossa M, et al. Triaging and coding ophthalmic emergency: the Rome Eye Scoring System for Urgency and Emergency (RESCUE): a pilot study of 1,000 eye-dedicated emergency room patients. Eur J Ophthalmol. 2007 May-Jun;17(3):413-7. Resumo

4. Ramos M, Kruger EF, Lashkari K. Biostatistical analysis of pseudophakic and aphakic retinal detachments. Semin Ophthalmol. 2002 Sep-Dec;17(3-4):206-13. Resumo

5. Klig JE. Ophthalmologic complications of systemic disease. Emerg Med Clin North Am. 2008 Feb;26(1):217-31. Resumo

6. De Silva I, Thomas MG, Shirodkar AL, et al; BEECS Study Group, Buchan J, Verma S. Patterns of attendances to the hospital emergency eye care service: a multicentre study in England. Eye (Lond). 2021 Nov 30:1-8.Texto completo  Resumo

7. Fea A, Bosone A, Rolle T, et al. Eye injuries in an Italian urban population: report of 10,620 cases admitted to an eye emergency department in Torino. Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):175-9. Resumo

8. Galindo-Ferreiro A, Sanchez-Tocino H, Varela-Conde Y, et al. Ocular emergencies presenting to an emergency department in Central Spain from 2013 to 2018. Eur J Ophthalmol. 2021 Mar;31(2):748-53. Resumo

9. Jones HL, Walker EA, Schechter CB, et al. Vision is precious: a successful behavioral intervention to increase the rate of screening for diabetic retinopathy for inner-city adults. Diabetes Educ. 2010 Jan-Feb;36(1):118-26.Texto completo  Resumo

10. Solomon SD, Chew E, Duh EJ, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care. 2017 Mar;40(3):412-8.Texto completo  Resumo

11. Mitra A, Chavan R, Gunda M. Occult giant cell arteritis and steroid therapy: how urgent is urgent? Ann Ophthalmol (Skokie). 2006 Winter;38(4):343-5. Resumo

12. Chidambaram JD. Recent advances in the diagnosis and management of bacterial keratitis. Int Ophthalmol Clin. 2007 Summer;47(3):1-6. Resumo

13. Beck RW, Trobe JD, Moke PS, et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol. 2003 Jul;121(7):944-9. Resumo

14. National Institute for Health and Care Excellence. Glaucoma: diagnosis and management. Jan 2022 [internet publication].Texto completo

15. National Health and Medical Research Council. Systematic literature review on the detection, diagnosis, management and prevention of glaucoma. Jun 2009 [internet publication].Texto completo

16. Dayan M, Turner B, McGhee C. Acute angle closure glaucoma masquerading as systemic illness. BMJ. 1996 Aug 17;313(7054):413-5.Texto completo  Resumo

17. Mitchell P, Liew G, Gopinath B, et al. Age-related macular degeneration. Lancet. 2018 Sep 29;392(10153):1147-59.Texto completo  Resumo

18. Hollands H, Johnson D, Brox AC, et al. Acute-onset floaters and flashes: is this patient at risk for retinal detachment? JAMA. 2009 Nov 25;302(20):2243-9. Resumo

19. Prisco D, Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):308-11.Texto completo  Resumo

20. Wong TY, Klein R. Retinal arteriolar emboli: epidemiology and risk of stroke. Curr Opin Ophthalmol. 2002 Jun;13(3):142-6. Resumo

21. Bora NS, Kaplan HJ. Intraocular diseases: anterior uveitis. Chem Immunol Allergy. 2007;92:213-20. Resumo

22. Desapriya E, Harjee R, Brubacher J, et al. Vision screening of older drivers for preventing road traffic injuries and fatalities. Cochrane Database Syst Rev. 2014 Feb 21;(2):CD006252.Texto completo  Resumo

23. US Preventive Services Task Force. Screening for impaired visual acuity in older adults: US Preventive Services Task Force recommendation statement. JAMA. 2022 Jun 7;327(21):2123-8.Texto completo  Resumo

24. Song P, Xu Y, Zha M, et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019 Jun;9(1):010427.Texto completo  Resumo

25. The Royal College of Ophthalmologists. Retinal vein occlusion (RVO) guidelines. Feb 2022 [internet publication].Texto completo

26. Flaxel CJ, Adelman RA, Bailey ST, et al. Retinal vein occlusions preferred practice pattern. Ophthalmology. 2020 Feb;127(2):288-320.Texto completo  Resumo

27. Walker L, King M. This month's guideline: visual loss secondary to cosmetic filler injection. J Clin Aesthet Dermatol. 2018 May;11(5):E53-5.Texto completo  Resumo

28. Kvickström P, Lindblom B, Bergström G, et al. Amaurosis fugax: risk factors and prevalence of significant carotid stenosis. Clin Ophthalmol. 2016;10:2165-70.Texto completo  Resumo

29. Therkildsen P, de Thurah A, Faurschou M, et al. A nationwide study of ocular manifestations leading to hospital contacts among patients with giant cell arteritis. Semin Arthritis Rheum. 2022 Oct;56:152071.Texto completo  Resumo

30. Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002 Sep;134(3):317-28. Resumo

31. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74. Resumo

32. Cavallini GM, Masini C, Volante V, et al. Visual recovery after scleral buckling for macula-off retinal detachments: an optical coherence tomography study. Eur J Ophthalmol. 2007 Sep-Oct;17(5):790-6. Resumo

33. Mac Grory B, Lavin P, Kirshner H, et al. Thrombolytic therapy for acute central retinal artery occlusion. Stroke. 2020 Feb;51(2):687-95.Texto completo  Resumo

34. Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2019;242(3):123-62.Texto completo  Resumo

35. Muthukumar N, Rossette D, Soundaram M, et al. Blindness following pituitary apoplexy: Timing of surgery and neuro-ophthalmic outcome. J Clin Neurosci. 2008 Aug;15(8):873-9. Resumo

36. Semple PL, Jane JA, Lopes MB, et al. Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results. J Neurosurg. 2008 May;108(5):909-15. Resumo

37. Barkhoudarian G, Kelly DF. Pituitary apoplexy. Neurosurg Clin N Am. 2019 Oct;30(4):457-63. Resumo

38. Iglesias P. Pituitary apoplexy: An updated review. J Clin Med. 2024 Apr 24;13(9):2508.Texto completo  Resumo

39. Dasgupta B; Giant Cell Arteritis Guideline Development Group. Concise guidance: diagnosis and management of giant cell arteritis. Clin Med (Lond). 2010 Aug;10(4):381-6. Resumo

40. Ponte C, Grayson PC, Robson JC, et al. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022 Dec;81(12):1647-53.Texto completo  Resumo

41. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-418.Texto completo  Resumo

42. Schmidt GW, Broman AT, Hindman HB, et al. Vision survival after open globe injury predicted by classification and regression tree analysis. Ophthalmology. 2008 Jan;115(1):202-9. Resumo

43. Kanoff JM, Turalba AV, Andreoli MT, et al. Characteristics and outcomes of work-related open globe injuries. Am J Ophthalmol. 2010 Aug;150(2):265-9. Resumo

44. Loong SC. The eye in neurology: evaluation of sudden visual loss and diplopia--diagnostic pointers and pitfalls. Ann Acad Med Singapore. 2001 Mar;30(2):143-7. Resumo

45. American Society of Anesthesiologists. Practice advisory for perioperative visual loss associated with spine surgery 2019: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Visual Loss, the North American Neuro-Ophthalmology Society, and the Society for Neuroscience in Anesthesiology and Critical Care. Anesthesiology. 2019 Jan;130(1):12-30.Texto completo  Resumo

46. Baj J, Forma A, Kobak J, et al. Toxic and nutritional optic neuropathies - an updated mini-review. Int J Environ Res Public Health. 2022 Mar 6;19(5):3092.Texto completo  Resumo

47. Grzybowski A, Zülsdorff M, Wilhelm H, et al. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015 Aug;93(5):402-10.Texto completo  Resumo

48. Michaelides M, Stover NB, Francis PJ, et al. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Arch Ophthalmol. 2011 Jan;129(1):30-9.Texto completo  Resumo

49. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014 Dec;132(12):1453-60.Texto completo  Resumo

50. Flahavan EM, Li H, Gupte-Singh K, et al. Prospective case-crossover study investigating the possible association between nonarteritic anterior ischemic optic neuropathy and phosphodiesterase type 5 inhibitor exposure. Urology. 2017 Jul;105:76-84. Resumo

51. Campbell UB, Walker AM, Gaffney M, et al. Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors. J Sex Med. 2015 Jan;12(1):139-51. Resumo

52. Liu B, Zhu L, Zhong J, et al. The association between phosphodiesterase type 5 inhibitor use and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. Sex Med. 2018 Sep;6(3):185-92.Texto completo  Resumo

53. Purvin V, Kawasaki A, Borruat FX. Optic neuropathy in patients using amiodarone. Arch Ophthalmol. 2006 May;124(5):696-701.Texto completo  Resumo

54. Pandit RJ, Gales K, Griffiths PG. Effectiveness of testing visual fields by confrontation. Lancet. 2001 Oct 20;358(9290):1339-40. Resumo

55. Donahue SP, Baker CN; American Academy of Pediatrics; American Association of Certified Orthoptists; American Association for Pediatric Ophthalmology and Strabismus; American Academy of Ophthalmology. Procedures for the evaluation of the visual system by pediatricians. Pediatrics. 2016 Jan;137(1). (Reaffirmed Feb 2022).Texto completo  Resumo

56. Xie JS, Donaldson L, Margolin E. Papilledema: a review of etiology, pathophysiology, diagnosis, and management. Surv Ophthalmol. 2022 Jul-Aug;67(4):1135-59. Resumo

57. Bargiela D, Chinnery PF. Mitochondria in neuroinflammation - multiple sclerosis (MS), leber hereditary optic neuropathy (LHON) and LHON-MS. Neurosci Lett. 2019 Sep 25;710:132932.Texto completo  Resumo

58. Gedde SJ, Chen PP, Muir KW, et al. Primary angle-closure disease preferred practice pattern®. Ophthalmology. 2021 Jan;128(1):P30-70. Resumo

59. Flaxel CJ, Adelman RA, Bailey ST, et al. Posterior vitreous detachment, retinal breaks, and lattice degeneration Preferred Practice Pattern®. Ophthalmology. 2020 Jan;127(1):P146-81.Texto completo  Resumo

60. Flaxel CJ, Adelman RA, Bailey ST, et al. Retinal and ophthalmic artery occlusions Preferred Practice Pattern®. Ophthalmology. 2020 Feb;127(2):P259-87.Texto completo  Resumo

61. Hellmich B, Agueda A, Monti S, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020 Jan;79(1):19-30.Texto completo  Resumo

62. Mackie SL, Dejaco C, Appenzeller S, et al. British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis. Rheumatology (Oxford). 2020 Mar 1;59(3):e1-23.Texto completo  Resumo

63. Mollan SP, Paemeleire K, Versijpt J, et al. European Headache Federation recommendations for neurologists managing giant cell arteritis. J Headache Pain. 2020 Mar 17;21(1):28.Texto completo  Resumo

64. Dejaco C, Ramiro S, Bond M, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis. 2023 Aug 7.Texto completo  Resumo

65. Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and takayasu arteritis. Arthritis Rheumatol. 2021 Aug;73(8):1349-65.Texto completo  Resumo